Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia.
about
Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@en
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@nl
type
label
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@en
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@nl
prefLabel
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@en
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@nl
P2093
P2860
P1476
Modulation of Navitoclax Sensi ...... Acute Lymphoblastic Leukemia.
@en
P2093
Anisha Kothari
Charles G Mullighan
David Finkelstein
Ewa Kaminska
John C Panetta
Joseph T Opferman
Meghan E Turnis
Michelle L Churchman
P2860
P304
P356
10.1158/1078-0432.CCR-17-1231
P407
P577
2017-10-03T00:00:00Z